Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 25,297
Sort by:

Paracetamol IV Market Size, Share and Growth Outlook 2026: By Indication (Pain Management, Pyrexia), By Application Type, By Patient Demographic, By End Use, Companies to 2034.

US$ 3,482.00

The global Paracetamol IV Market size is forecast to increase from $926.58 Million in 2026 to $1248.71 Million in 2034 at a CAGR of 3.8% between 2026 and 2034. The Paracetamol IV market report provide...

July 2026 190 pages

Parenteral Nutrition Market Size, Share and Growth Outlook 2026: By Nutrient Type, By Patient Stage, By Therapeutic Indication, By Sales and Distribution Channel, Companies to 2034

US$ 3,482.00

The global Parenteral Nutrition Market size is forecast to increase from $8.01 Billion in 2026 to $12.52 Billion in 2034 at a CAGR of 5.74% between 2026 and 2034. The Parenteral Nutrition market repor...

July 2026 190 pages

Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Share and Growth Outlook 2026: By Treatment, By Route of Administration, By Patient Group, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Paroxysmal Nocturnal Hemoglobinuria Treatment Market size is forecast to increase from $6.77 Billion in 2026 to $14.03 Billion in 2034 at a CAGR of 9.54% between 2026 and 2034. The Paroxysm...

July 2026 190 pages

Peptide Antibiotics Market Size, Share and Growth Outlook 2026: By Product Type, By Disease, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Peptide Antibiotics Market size is forecast to increase from $5.62 Billion in 2026 to $8.42 Billion in 2034 at a CAGR of 5.18% between 2026 and 2034. The Peptide Antibiotics market report p...

July 2026 190 pages

Pharmaceutical Contract Sales Organizations Market Size, Share and Growth Outlook 2026: By Service, By End User, Companies to 2034

US$ 3,482.00

The global Pharmaceutical Contract Sales Organizations Market size is forecast to increase from $26.63 Billion in 2026 to $53.57 Billion in 2034 at a CAGR of 9.13% between 2026 and 2034. The Pharmaceu...

July 2026 190 pages

Pharmaceutical Manufacturing Market Size, Share and Growth Outlook 2026: By Molecule Type (Small Molecules, Biologics, Biosimilars, Specialty Therapeutic Compounds), By Drug Development, By Therapy Area, By Sales Channel, Companies to 2034.

US$ 3,482.00

The global Pharmaceutical Manufacturing Market size is forecast to increase from $703.92 Billion in 2026 to $1128.73 Billion in 2034 at a CAGR of 6.08% between 2026 and 2034. The Pharmaceutical Manufa...

July 2026 190 pages

Pharmaceutical Market Size, Share and Growth Outlook 2026: By Molecule Type, By Drug Type, By Type of Coverage, By Therapeutic Area, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Pharmaceutical Market size is forecast to increase from $2107.44 Billion in 2026 to $3464.29 Billion in 2034 at a CAGR of 6.41% between 2026 and 2034. The Pharmaceutical market report provi...

July 2026 190 pages

Pharmerging Market Size, Share and Growth Outlook 2026: By Product Type (Branded Generics, Patented Drugs, OTC Pharmaceuticals, Biosimilars, Vaccines), By Therapeutic Area, By Distribution Channel, By Formulation, By Economy Tier, Companies to 2034.

US$ 3,482.00

The global Pharmerging Market size is forecast to increase from $1799.98 Million in 2026 to $2323.01 Million in 2034 at a CAGR of 3.24% between 2026 and 2034. The Pharmerging market report provides de...

July 2026 190 pages

Plant-based API Market Size, Share and Growth Outlook 2026: By Product Type (Amino Acids, Alkaloids, Glycosides, Flavonoids, Terpenoids, Polyphenols, Others), By Application, By Extraction Method, By End User, Companies to 2034.

US$ 3,482.00

The global Plant-based API Market size is forecast to increase from $36.67 Billion in 2026 to $59.42 Billion in 2034 at a CAGR of 6.22% between 2026 and 2034. The Plant-based API market report provide...

July 2026 190 pages

Plant-based Excipients Market Size, Share and Growth Outlook 2026: By Chemical Nature (Carbohydrates, Proteins and Amino Acids, Oleochemicals, Minerals and Others), By Functionality, By Formulation Type, Companies to 2034.

US$ 3,482.00

The global Plant-based Excipients Market size is forecast to increase from $2.23 Billion in 2026 to $3.14 Billion in 2034 at a CAGR of 4.39% between 2026 and 2034. The Plant-based Excipients market re...

July 2026 190 pages

Preclinical CRO Market Size, Share and Growth Outlook 2026: By Service, By Development Stage, By Indication, By Model, By End-Use, Companies to 2034

US$ 3,482.00

The global Preclinical CRO Market size is forecast to increase from $7.74 Billion in 2026 to $14.6 Billion in 2034 at a CAGR of 8.26% between 2026 and 2034. The Preclinical CRO market report provides...

July 2026 190 pages

Primary Biliary Cholangitis Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Class, By Mechanism of Action, By Line of Therapy, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Primary Biliary Cholangitis Therapeutics Market size is forecast to increase from $907.67 Million in 2026 to $1635.75 Million in 2034 at a CAGR of 7.64% between 2026 and 2034. The Primary B...

July 2026 190 pages

Rare Disease Clinical Trials Market Size, Share and Growth Outlook 2026: By Phase (Phase I, Phase II, Phase III, Phase IV), By Therapeutic Area, By Design, By Sponsor, Companies to 2034.

US$ 3,482.00

The global Rare Disease Clinical Trials Market size is forecast to increase from $14.43 Billion in 2026 to $25.28 Billion in 2034 at a CAGR of 7.26% between 2026 and 2034. The Rare Disease Clinical Tr...

July 2026 190 pages

Respiratory Disease Vaccine Market Size, Share and Growth Outlook 2026: By Product Type, By Vaccine Technology, By Pathogen Target, By Age Group, By Application, Companies to 2034

US$ 3,482.00

The global Respiratory Disease Vaccine Market size is forecast to increase from $23.88 Billion in 2026 to $42.46 Billion in 2034 at a CAGR of 7.46% between 2026 and 2034. The Respiratory Disease Vacci...

July 2026 190 pages

RNA Therapy Clinical Trials Market Size, Share and Growth Outlook 2026: By Modality, By Phase of Development, By Therapeutic Area, By Service Provider, Companies to 2034

US$ 3,482.00

The global RNA Therapy Clinical Trials Market size is forecast to increase from $2.85 Billion in 2026 to $3.89 Billion in 2034 at a CAGR of 3.96% between 2026 and 2034. The RNA Therapy Clinical Trials...

July 2026 190 pages

Shingles Vaccine Market Size, Share and Growth Outlook 2026: By Vaccine Type (Recombinant Zoster Vaccines, Live Attenuated Zoster Vaccines, mRNA-Based Zoster Vaccines), By Indication, By End Use, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Shingles Vaccine Market size is forecast to increase from $5.96 Billion in 2026 to $19.84 Billion in 2034 at a CAGR of 16.22% between 2026 and 2034. The Shingles Vaccine market report provi...

July 2026 190 pages

Synthetic Small Molecule API Market Size, Share and Growth Outlook 2026: By Molecule Type (Standard API, High Potency API (HPAPI)), By Manufacturing Model, By Application, By Therapeutic Area, By Manufacturing Scale, Companies to 2034.

US$ 3,482.00

The global Synthetic Small Molecule API Market size is forecast to increase from $188.07 Billion in 2026 to $295.48 Billion in 2034 at a CAGR of 5.81% between 2026 and 2034. The Synthetic Small Molecu...

July 2026 190 pages

Systemic Scleroderma Treatment Market Size, Share and Growth Outlook 2026: By Drug Class, By Symptom, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Systemic Scleroderma Treatment Market size is forecast to increase from $1.81 Billion in 2026 to $2.75 Billion in 2034 at a CAGR of 5.36% between 2026 and 2034. The Systemic Scleroderma Tre...

July 2026 190 pages

Transthyretin Amyloidosis Treatment Market Size, Share and Growth Outlook 2026: By Drug Type (Tafamidis (Vyndaqel), Patisiran (ONPATTRO), Inotersen (TEGSEDI), Others), By Disease Type, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Transthyretin Amyloidosis Treatment Market size is forecast to increase from $7.67 Billion in 2026 to $20.17 Billion in 2034 at a CAGR of 12.85% between 2026 and 2034. The Transthyretin Amy...

July 2026 190 pages

Immunosuppressants Market Size, Share and Growth Outlook 2026: By Drug Class, By Indication, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Immunosuppressants Market size is forecast to increase from $465.65 Billion in 2026 to $1347.06 Billion in 2034 at a CAGR of 14.2% between 2026 and 2034. The Immunosuppressants market repor...

July 2026 190 pages

Inflammatory Bowel Disease Market Size, Share and Growth Outlook 2026: By Disease Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Inflammatory Bowel Disease Market size is forecast to increase from $23.44 Billion in 2026 to $33.08 Billion in 2034 at a CAGR of 4.4% between 2026 and 2034. The Inflammatory Bowel Disease...

July 2026 190 pages

Injectable Drugs Market Size, Share and Growth Outlook 2026: By Product Type, By Route of Administration, By Therapeutic Application, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Injectable Drugs Market size is forecast to increase from $723.52 Billion in 2026 to $1309.71 Billion in 2034 at a CAGR of 7.7% between 2026 and 2034. The Injectable Drugs market report pro...

July 2026 190 pages

Interstitial Cystitis Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Type, By Route of Administration, By Formulation Type, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Interstitial Cystitis Drugs Market size is forecast to increase from $1.37 Billion in 2026 to $2.07 Billion in 2034 at a CAGR of 5.3% between 2026 and 2034. The Interstitial Cystitis Drugs...

July 2026 190 pages

Iron Drugs Market Size, Share and Growth Outlook 2026: By Product Type (Ferric Carboxymaltose, Iron Sucrose, Iron Dextran, Ferric Gluconate, Iron Isomaltoside), By Application, By End-User, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Iron Drugs Market size is forecast to increase from $8.89 Billion in 2026 to $19.48 Billion in 2034 at a CAGR of 10.3% between 2026 and 2034. The Iron Drugs market report provides detailed...

July 2026 190 pages

Irritable Bowel Syndrome Market Size, Share and Growth Outlook 2026: By Symptom Type, By Product, By Consumer Demographics, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Irritable Bowel Syndrome Market size is forecast to increase from $4.2 Billion in 2026 to $7.89 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034. The Irritable Bowel Syndrome market...

July 2026 190 pages

Kidney Transplantation Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Class, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Kidney Transplantation Therapeutics Market size is forecast to increase from $10.6 Billion in 2026 to $18.76 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034. The Kidney Transplantat...

July 2026 190 pages

Krabbe Disease Treatment Market Size, Share and Growth Outlook 2026: By Therapy Type, By Disease Type, By End User, Companies to 2034

US$ 3,482.00

The global Krabbe Disease Treatment Market size is forecast to increase from $1.18 Billion in 2026 to $2.12 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034. The Krabbe Disease Treatment market...

July 2026 190 pages

Leuprolide Acetate Market Size, Share and Growth Outlook 2026: By Product Form (Immediate-Release Injection, 1-Month Depot, 3-Month Depot, 6-Month Depot, 12-Month Depot), By Application, By End-User, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Leuprolide Acetate Market size is forecast to increase from $2.83 Billion in 2026 to $5.76 Billion in 2034 at a CAGR of 9.3% between 2026 and 2034. The Leuprolide Acetate market report prov...

July 2026 190 pages

Liver Cirrhosis Therapeutics Market Size, Share and Growth Outlook 2026: By Treatment Type, By Disease Indication, By Stage Type, By End User, Companies to 2034

US$ 3,482.00

The global Liver Cirrhosis Therapeutics Market size is forecast to increase from $3.52 Billion in 2026 to $7.88 Billion in 2034 at a CAGR of 10.6% between 2026 and 2034. The Liver Cirrhosis Therapeuti...

July 2026 190 pages

Liver Disease Treatment Market Size, Share and Growth Outlook 2026: By Treatment Type, By Disease, By Route of Administration, By End User, Companies to 2034

US$ 3,482.00

The global Liver Disease Treatment Market size is forecast to increase from $22.6 Billion in 2026 to $35.75 Billion in 2034 at a CAGR of 5.9% between 2026 and 2034. The Liver Disease Treatment market...

July 2026 190 pages

LVAD (Left Ventricular Assist Device) Market Size, Share and Growth Outlook 2026: By Flow Type (Continuous Flow, Pulsatile Flow), By Design Type, By Indication, By End-User, Companies to 2034.

US$ 3,482.00

The global LVAD (Left Ventricular Assist Device) Market size is forecast to increase from $1.51 Billion in 2026 to $2.84 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034. The Left Ventricular A...

July 2026 190 pages

mAb Biosimilars Market Size, Share and Growth Outlook 2026: By Type, By Therapeutic Application, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global mAb Biosimilars Market size is forecast to increase from $15.79 Billion in 2026 to $40.8 Billion in 2034 at a CAGR of 12.6% between 2026 and 2034. The mAb Biosimilars market report provides...

July 2026 190 pages

Medical Mattresses Market Size, Share and Growth Outlook 2026: By Product Type (Foam Mattresses, Air Mattresses, Gel Mattresses, Innerspring Mattresses, Hybrid Mattresses), By Usability, By Distribution Channel, By End User, Companies to 2034.

US$ 3,482.00

The global Medical Mattresses Market size is forecast to increase from $8.95 Billion in 2026 to $15.26 Billion in 2034 at a CAGR of 6.9% between 2026 and 2034. The Medical Mattresses market report pro...

July 2026 190 pages

Mono Vaccine Market Size, Share and Growth Outlook 2026: By Vaccine Type, By Target Indication, By End-User, Companies to 2034

US$ 3,482.00

The global Mono Vaccine Market size is forecast to increase from $12.13 Billion in 2026 to $17.65 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034. The Mono Vaccine market report provides detai...

July 2026 190 pages

Musculoskeletal Disorders Therapeutics Market Size, Share and Growth Outlook 2026: By Disease Type (Arthritis, Osteoporosis, Fibromyalgia, Others), By Molecule Type, By Treatment Type, By End-User, Companies to 2034.

US$ 3,482.00

The global Musculoskeletal Disorders Therapeutics Market size is forecast to increase from $224.6 Billion in 2026 to $360.69 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034. The Musculoskeleta...

July 2026 190 pages

Myasthenia Gravis Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Treatment Type, By Route of Administration, By End-User, Companies to 2034

US$ 3,482.00

The global Myasthenia Gravis Drugs Market size is forecast to increase from $2.82 Billion in 2026 to $5.54 Billion in 2034 at a CAGR of 8.8% between 2026 and 2034. The Myasthenia Gravis Drugs market r...

July 2026 190 pages

Neuromuscular Disease Therapeutics Market Size, Share and Growth Outlook 2026: By Disease, By Drug, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neuromuscular Disease Therapeutics Market size is forecast to increase from $17.24 Billion in 2026 to $49.52 Billion in 2034 at a CAGR of 14.1% between 2026 and 2034. The Neuromuscular Dise...

July 2026 190 pages

Non-alcoholic Fatty Liver Disease Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Class, By Route of Administration, By Distribution Channel, By Age Group, By Complication Type, Companies to 2034

US$ 3,482.00

The global Non-alcoholic Fatty Liver Disease Therapeutics Market size is forecast to increase from $24.18 Billion in 2026 to $49.61 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034. The Non-alc...

July 2026 190 pages

Osteoarthritis Market Size, Share and Growth Outlook 2026: By Anatomy, By Treatment Type, By Drug Type, By Route of Administration, By Diagnosis, By End-User, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Osteoarthritis Market size is forecast to increase from $10.23 Billion in 2026 to $17.45 Billion in 2034 at a CAGR of 6.9% between 2026 and 2034. The Osteoarthritis market report provides d...

July 2026 190 pages

Osteoarthritis Pain Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Route of Administration, By Application, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Osteoarthritis Pain Drugs Market size is forecast to increase from $9.46 Billion in 2026 to $15.77 Billion in 2034 at a CAGR of 6.6% between 2026 and 2034. The Osteoarthritis Pain Drugs mar...

July 2026 190 pages

Osteonecrosis Therapeutics Market Size, Share and Growth Outlook 2026: By Treatment Class, By Route of Administration, By Indication, By End User, Companies to 2034

US$ 3,482.00

The global Osteonecrosis Therapeutics Market size is forecast to increase from $865.33 Million in 2026 to $1475.72 Million in 2034 at a CAGR of 6.9% between 2026 and 2034. The Osteonecrosis Therapeuti...

July 2026 190 pages

Overactive Bladder Therapeutics Market Size, Share and Growth Outlook 2026: By Pharmacotherapy, By Disease Type, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Overactive Bladder Therapeutics Market size is forecast to increase from $4.29 Billion in 2026 to $6.29 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034. The Overactive Bladder Thera...

July 2026 190 pages

Pain Management Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Indication, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Pain Management Drugs Market size is forecast to increase from $80.89 Billion in 2026 to $115.92 Billion in 2034 at a CAGR of 4.6% between 2026 and 2034. The Pain Management Drugs market re...

July 2026 190 pages

Pediatric Medicines Market Size, Share and Growth Outlook 2026: By Drug Type, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Pediatric Medicines Market size is forecast to increase from $156.23 Billion in 2026 to $304.51 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034. The Pediatric Medicines market repor...

July 2026 190 pages

Penicillin Market Size, Share and Growth Outlook 2026: By Source Type (Natural Penicillin, Semi-Synthetic Penicillin), By Route of Administration, By Indication, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Penicillin Market size is forecast to increase from $9.64 Billion in 2026 to $13.09 Billion in 2034 at a CAGR of 3.9% between 2026 and 2034. The Penicillin market report provides detailed a...

July 2026 190 pages

Peptic Ulcer Drugs Market Size, Share and Growth Outlook 2026: By Product (Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs, Antibiotics), By Application, Companies to 2034.

US$ 3,482.00

The global Peptic Ulcer Drugs Market size is forecast to increase from $5.33 Billion in 2026 to $6.6 Billion in 2034 at a CAGR of 2.7% between 2026 and 2034. The Peptic Ulcer Drugs market report provi...

July 2026 190 pages

Pleurodynia Treatment Market Size, Share and Growth Outlook 2026: By Treatment Modality, By Symptoms, By Complications, By Patient Type, By Healthcare Setting, Companies to 2034

US$ 3,482.00

The global Pleurodynia Treatment Market size is forecast to increase from $115.2 Million in 2026 to $150.53 Million in 2034 at a CAGR of 3.4% between 2026 and 2034. The Pleurodynia Treatment market re...

July 2026 190 pages

Pneumococcal Vaccine Market Size, Share and Growth Outlook 2026: By Vaccine Type (Pneumococcal Conjugate Vaccines, Pneumococcal Polysaccharide Vaccines), By Product, By Target Population, By Sector, Companies to 2034.

US$ 3,482.00

The global Pneumococcal Vaccine Market size is forecast to increase from $9.44 Billion in 2026 to $15.51 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034. The Pneumococcal Vaccine market report...

July 2026 190 pages

Polio Vaccines Market Size, Share and Growth Outlook 2026: By Vaccine Type (Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV), Combination Vaccines), By Application, By End-User, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Polio Vaccines Market size is forecast to increase from $997.28 Million in 2026 to $1323.41 Million in 2034 at a CAGR of 3.6% between 2026 and 2034. The Polio Vaccines market report provide...

July 2026 190 pages

Polycystic Kidney Disease Drugs Market Size, Share and Growth Outlook 2026: By Therapeutic Class, By Disease Type, By Mode of Administration, By Distribution Channel, By End-User, Companies to 2034

US$ 3,482.00

The global Polycystic Kidney Disease Drugs Market size is forecast to increase from $471.51 Million in 2026 to $718.15 Million in 2034 at a CAGR of 5.4% between 2026 and 2034. The Polycystic Kidney Di...

July 2026 190 pages

Filters

Search

Categories

115
13,922
9,937
310
72
941

Publishers

72
1
322
469
292
33
4
1,872
635
92
2,138
8
109
111
554
7
55
5
5
6
23
18
18
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
83
4
26
50
1
139
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
81
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
246
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
183
13
12
8
431
233
125
56
49
32
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
22,698

Price

Date

Pages

Offers

44
5
1